Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. 

Biotechnology

Genmab

Genmab's headquarters in Copenhagen, Denmark

Jan G. J. van de Winkel

Anthony Pagano

Christopher Cozic

Jacob Brogaard-Kay

Leslie C Amendola

Dan Zebrowski

Priya Mahale

Martine van Vugt

Peter Louwagie

Michelle Pleiter

Martine J. van Vugt

Tahamtan Ahmadi

Birgitte Stephensen

Anders Gersel Pedersen

Paolo Paoletti

Rolf Hoffmann

Mijke Zachariasse

Deirdre P. Connelly

Martin Schultz

Elizabeth O’Farrell

Takahiro Hamatani

The Data Science and Analytics team at Genmab leverages advanced data analysis, machine learning, and artificial intelligence to extract insights from research and clinical data, optimize drug discovery processes, and enhance the development of antibody therapeutics. This cross-functional team collaborates closely with various departments to support data-driven decision making and improve the efficacy and safety of cancer treatments.

Data Science and Analytics

The Leadership Team at Genmab plays a critical role in driving the company’s strategic direction and operational execution in the development of innovative antibody therapeutics for cancer. Comprising top executives across various functions, including operations, finance, legal affairs, development, and clinical research, the team collaborates to ensure alignment on corporate objectives, regulatory compliance, and overall business performance. Their collective expertise guides Genmab in navigating the complex biotechnology landscape to deliver impactful therapies to patients.

Leadership Team

��

Genmab

Org chart

Board & advisors

Teams

Data Science and Analytics

Leadership Team

Offices

��������

Genmab

Org chart

Board & advisors

Teams

Data Science and Analytics

Leadership Team

Offices

Related companies

��